![Allan John Syms](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Allan John Syms
Directeur/Membre du Conseil chez Cizzle Biotech Ltd.
Postes actifs de Allan John Syms
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cizzle Biotech Ltd.
![]() Cizzle Biotech Ltd. SemiconductorsElectronic Technology Cizzle Biotech Ltd. designs and manufactures semiconductors. The firm services include providing advanced LED technology solutions and systems such as semiconductor light emitting diodes and laser diode devices to the medical, industrial and consumer markets. The company was founded in 2001 and is headquartered in Romsey, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Cizzle Biotechnology Ltd.
![]() Cizzle Biotechnology Ltd. BiotechnologyHealth Technology Cizzle Biotechnology Ltd. develops therapeutic products for lung cancer. The firm promotes DNA replication and is involved in its organization and control. The company was founded by Dawn Coverley and Justin Ainscough in 2005 and is headquartered in York, the United Kingdom. | Directeur/Membre du Conseil | 16/07/2021 | - |
Historique de carrière de Allan John Syms
Statistiques
Internationale
Royaume-Uni | 3 |
Opérationnelle
Director/Board Member | 2 |
Sectorielle
Electronic Technology | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Cizzle Biotech Ltd.
![]() Cizzle Biotech Ltd. SemiconductorsElectronic Technology Cizzle Biotech Ltd. designs and manufactures semiconductors. The firm services include providing advanced LED technology solutions and systems such as semiconductor light emitting diodes and laser diode devices to the medical, industrial and consumer markets. The company was founded in 2001 and is headquartered in Romsey, the United Kingdom. | Electronic Technology |
Cizzle Biotechnology Ltd.
![]() Cizzle Biotechnology Ltd. BiotechnologyHealth Technology Cizzle Biotechnology Ltd. develops therapeutic products for lung cancer. The firm promotes DNA replication and is involved in its organization and control. The company was founded by Dawn Coverley and Justin Ainscough in 2005 and is headquartered in York, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Allan John Syms
- Expérience